Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Peter Lattke"'
Publikováno v:
labm. 37:187-197
Zusammenfassung: Phäochromozytome, Paragangliome und Neuroblastome sind seltene neuroendokrine Tumoren, die durch eine erhöhte Katecholaminproduktion charakterisiert sind. Die Katecholamine werden noch in den Tumorzellen zu Metanephrinen O-methylie
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 54
Measurements of urinary fractionated metadrenalines provide a useful screening test to diagnose phaeochromocytoma. Stability of these compounds and their parent catecholamines during and after urine collection is crucial to ensure accuracy of the mea
Autor:
Peter Lattke, Albert Hagelgans, Iskander I. Ismailov, Mario Menschikowski, Gabriele Siegert, Ute Hempel
Publikováno v:
Thrombosis Research. 122:69-76
Introduction Pharmacological restriction of secretory group IIA phospholipase A2 (sPLA2-IIA) expression is thought to be beneficial in the treatment of inflammatory diseases such as sepsis and septic shock. In this study we investigated the effects o
Autor:
Stefan R. Bornstein, Christian G. Ziegler, Alexander W. Krug, Peter Lattke, Monika Ehrhart-Bornstein, Flavie Sicard
Publikováno v:
Endocrinology. 149:320-328
The adrenal androgen dehydroepiandrosterone (DHEA) is produced in the inner zone of the adrenal cortex, which is in direct contact to adrenal medullary cells. Due to their close anatomical proximity and tightly intermingled cell borders, a direct int
Publikováno v:
Spine. 32:348-352
Cross-sectional study of 10 patients to measure the serum levels of cobalt and chromium after TDA.To investigate the release of cobalt and chromium ions into the serum following implantation of the metal-on-metal Maverick-type artificial lumbar disc.
Autor:
Ruidiger Siekmeier, Comnelia Mix, Stefan Schuiler, Mechthild Merz, Jai-Wun Park, Werner Jaross, Peter Lattke
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics. 6:351-361
During the last decades, transplantation has become an established tool for the treatment of terminal organ failure. Beside immunological factors, hyperlipidemia is the main problem after heart transplantation, causing rapid transplant coronary arter
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics. 6:137-145
Background: Fluvastatin is an inhibitor of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, effectively lowering serum cholesterol concentrations. A high-performance liquid chromatography (HPLC) assay was developed that determined the p
Publikováno v:
Atherosclerosis. 147:327-337
The aim of this investigation was to examine whether near infrared diffuse reflection spectroscopy is an acceptable tool for the determination of cholesterol content in atherosclerotic plaques. Using an FT-spectrophotometer ( λ =1000–2500 nm) and
Autor:
D. Meissner, Peter Lattke, Claudia Abletshauser, T. Kurktschiev, Hanefeld M, W. Jaross, Leonhardt W, G. Weidinger
Publikováno v:
European Journal of Clinical Pharmacology. 53:65-69
Oxidation of low density lipoproteins (LDL) is thought to be an important step in the development of atherosclerosis. Trace metals are involved in oxidative processes. It was of interest to determine whether lipid-lowering therapy with fluvastatin, a
Autor:
Heinz Reichmann, Gabriele Siegert, Mirko Peitzsch, Stephan Glöckner, Aleksander Prejbisz, Andrzej Januszewicz, Graeme Eisenhofer, Peter Lattke, Felix Beuschlein, Sebastian Brown, Anthony Stell, Martin Fassnacht, Daniela Pelzel
Publikováno v:
Annals of clinical biochemistry. 51(Pt 1)
Background Medication-related interferences with measurements of catecholamines and their metabolites represent important causes of false-positive results during diagnosis of phaeochromocytomas and paragangliomas (PPGLs). Such interferences are less